Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malariaSusan A. Charman, Jonathan L. Vennerstrom, Sarah Arbe‐Barnes et al.|Proceedings of the National Academy of Sciences|2011Cited by 379
dUTPase as a Platform for Antimalarial Drug Design: Structural Basis for the Selectivity of a Class of Nucleoside InhibitorsJean L. Whittingham, Keith S. Wilson, Emma Bell et al.|Structure|2005Cited by 99